登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600568 证券简称：ST中珠 公告编号：2025-062号 中珠医疗控股股份有限公司 股票交易异常波动的公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）股票于2025年11月21日、11月24日、11 月25日连续三个交易日内日收盘价格涨幅偏离值累计达到12%，根据《上海证券交易所交易规则》的有 关规定，属于股票交易异常波动情形。 ● 其他风险警示的风险：截至2024年度期末，因珠海中珠集团股份有限公司及其关联方资金占用问题尚 未解决，公司股票继续被实施其他风险警示。 ● 业绩亏损的风险：截至本公告披露日，公司最近连续三个会计年度归属于上市公司股东的扣除非经常 性损益后的净利润均为负值。2024年度，归属于上市公司股东的扣除非经常性损益的净利润-62,386.69 万元。 ● 业绩承诺兑现的风险：因深圳市一体医疗科技有限公司2017年度未完成承诺业绩，补偿方深圳市一体 投 ...

证券代码：600568 证券简称：ST 中珠 公告编号：2025-062 号 中珠医疗控股股份有限公司 股票交易异常波动的公告 特别提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 中珠医疗控股股份有限公司（以下简称"中珠医疗"或"公司"）股票于2025 年11月21日、11月24日、11月25日连续三个交易日内日收盘价格涨幅偏离值累计达到 12%，根据《上海证券交易所交易规则》的有关规定，属于股票交易异常波动情形。 其他风险警示的风险：截至2024年度期末，因珠海中珠集团股份有限公司及其 关联方资金占用问题尚未解决，公司股票继续被实施其他风险警示。 业绩亏损的风险：截至本公告披露日，公司最近连续三个会计年度归属于上市 公司股东的扣除非经常性损益后的净利润均为负值。2024年度，归属于上市公司股东 的扣除非经常性损益的净利润-62,386.69万元。 业绩承诺兑现的风险：因深圳市一体医疗科技有限公司2017年度未完成承诺业 绩，补偿方深圳市一体投资控股集团有限公司、深圳市一体正润资产管理有限公司（已 更名深 ...

详式权益变动报告书 上市公司名称：中珠医疗控股股份有限公司 股票上市地点：上海证券交易所 股票简称：ST 中珠 股票代码：600568 信息披露义务人：苏州步步高投资发展有限公司 住所：苏州市吴江区水秀街 500 号道谷商务大厦 401 室 通讯地址：南京市建邺区白龙江东街 26 号百胜步步高大厦 20 层 权益变动性质：股份增加（间接方式受让） 签署日期：二〇二五年十一月 信息披露义务人声明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 一、本报告书根据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司收购管理办法》《公开发行证券的公司信息披露内容与格式准则第 15 号— —权益变动报告书》《公开发行证券的公司信息披露内容与格式准则第 16 号—— 上市公司收购报告书》及其他相关法律、法规、部门规章及规范性文件的有关规定 编写。 中珠医疗控股股份有限公司 二、依据上述法律法规的规定，本报告书已全面披露信息披露义务人苏州步步 高投资发展有限公司在中珠医疗控股股份有限公司拥有权益的股份变动情况。 截至本报告书签署日，除本报告书披露的信息外，信息披露义务人没有通过任 何其他方式在中 ...

Market Overview - The medical services sector increased by 0.56% on November 25, with ST Zhongzhu leading the gains [1] - The Shanghai Composite Index closed at 3870.02, up 0.87%, while the Shenzhen Component Index closed at 12777.31, up 1.53% [1] Top Gainers in Medical Services - ST Zhongzhu (600568) closed at 2.57, up 4.90% with a trading volume of 53,900 shares and a turnover of 13.85 million yuan [1] - Chengda Pharmaceutical (301201) closed at 47.78, up 2.97% with a trading volume of 112,700 shares and a turnover of 540 million yuan [1] - Boji Pharmaceutical (300404) closed at 10.10, up 2.75% with a trading volume of 108,600 shares and a turnover of 10.9 million yuan [1] Top Losers in Medical Services - Jiuzhou Pharmaceutical (603456) closed at 18.75, down 0.85% with a trading volume of 181,100 shares and a turnover of 343 million yuan [2] - Tongce Medical (600763) closed at 41.95, down 0.66% with a trading volume of 49,600 shares and a turnover of 210 million yuan [2] - Yingkang Life (300143) closed at 10.12, down 0.49% with a trading volume of 44,700 shares and a turnover of 4.56 million yuan [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 113 million yuan from institutional investors, while retail investors saw a net inflow of 30.37 million yuan [2][3] - Major stocks like WuXi AppTec (603259) had a net inflow of 67.13 million yuan from institutional investors, while Sunshine Nuohua (688621) saw a net outflow of 2.29 million yuan from retail investors [3] Summary of Individual Stock Performance - Sunshine Nuohua (688621) had a net inflow of 38.24 million yuan from institutional investors, but a net outflow of 3.59 million yuan from retail investors [3] - Chengda Pharmaceutical (301201) also saw a significant net inflow of 36.45 million yuan from institutional investors, with a net outflow of 13.58 million yuan from retail investors [3] - New Mileage (002219) had a net inflow of 14.15 million yuan from institutional investors, while retail investors experienced a net outflow of 6.70 million yuan [3]

Core Viewpoint - ST Zhongzhu has experienced significant stock price increases, attributed to a major change in its shareholding structure, with the transfer of ownership to Suzhou Bubugao Investment Development Co., Ltd. [2][4] Group 1: Stock Performance - ST Zhongzhu's stock price reached a limit-up of 2.57 yuan per share, marking a 4.9% increase and a total market capitalization of 5.12 billion yuan [2] - This marks the seventh limit-up for ST Zhongzhu within the month [2] - The company reported a revenue of 430 million yuan for the first three quarters of this year, a year-on-year increase of 12.8% [3] Group 2: Shareholding Changes - Shenzhen Shenshang Group plans to transfer its 100% stake in the largest shareholder, Shenzhen Landi Technology Development Co., Ltd., to Suzhou Bubugao Investment for 30 million yuan [2] - After the transfer, the controlling shareholder of Landi Technology will change from Shenshang Group to Bubugao Investment [2] - Landi Technology has a total debt of 670 million yuan and a net asset of -1 million yuan as of mid-year [2][3] Group 3: Investment Insights - Bubugao Investment's acquisition is seen as a long-term investment based on the recognition of ST Zhongzhu's intrinsic value [4] - The controlling person of Bubugao Investment, Zhang Yuan, has a history of successful capital operations, including previous investments that yielded significant returns [4] - The recent interest from notable investors, including Mei Hua Venture Capital, indicates a growing confidence in ST Zhongzhu's potential [5][6]

Key Points - Industrial Fulian (601138.SH) has not lowered its profit target for the fourth quarter [1] - Shanghai Port Bay (605598.SH) reported that its commercial aerospace and perovskite solar business account for less than 1% of its revenue, indicating a small scale and no profitability yet [1] - Zhaohong Wanli (603210.SH) plans to establish a wholly-owned subsidiary to invest 480 million yuan in the construction of an automotive body structure component production line [1] - Tongji Technology (600846.SH) announced that its subsidiary won the bid for the Xi'an Heshan Jinxiu Mansion project construction [1] - ST Zhongzhu (600568.SH) revealed that Shen Shang Group intends to transfer 100% equity of Langdi Technology to Bubugao Investment for 30 million yuan [1] - Naxinwei (688052.SH) plans to repurchase shares worth between 200 million to 400 million yuan [1] - Star Entertainment (300043.SH) reported that its actual controller and concerted parties plan to reduce their holdings by no more than 2.9% [1] - Cixing Co., Ltd. (300307.SH) intends to raise no more than 300 million yuan through a private placement [2] - Zhongding Co., Ltd. (000887.SH) has become a supplier of liquid cooling dummy loads for two domestic liquid cooling system integrators [2]

Key Points - Industrial Fulian (601138.SH) has not lowered its profit target for the fourth quarter [1] - Shanghai Port Bay (605598.SH) reported that its commercial aerospace and perovskite solar business account for less than 1% of its revenue, indicating a small scale and no profitability [1] - Taihong Wanli (603210.SH) plans to establish a wholly-owned subsidiary to invest 480 million yuan in the construction of an automotive body structure component production line [1] - Tongji Technology (600846.SH) announced that its subsidiary won the construction bid for the Xi'an Heshan Jinxiu Mansion project [1] - ST Zhongzhu (600568.SH) revealed that Shen Shang Group intends to transfer 100% equity of Landi Technology to Bubugao Investment for 30 million yuan [1] - Naxinwei (688052.SH) plans to repurchase shares worth between 200 million to 400 million yuan [1] - Xinghui Entertainment (300043.SH) reported that its actual controller and concerted parties plan to reduce their holdings by no more than 2.9% [1] - Cixing Co., Ltd. (300307.SZ) intends to raise no more than 300 million yuan through a private placement [3] - Zhongding Co., Ltd. (000887.SZ) announced that its controlling subsidiary has become a supplier of liquid cooling dummy loads for two domestic liquid cooling system integrators [3]

Core Viewpoint - ST Zhongzhu (600568.SH) announced a significant equity transfer involving its subsidiary, Langdi Technology, which will change its controlling shareholder from Shenzhen Shenshang Holdings Group to Bubugao Investment [1] Group 1: Equity Transfer Details - The equity transfer was completed on November 24, 2025, with Bubugao Investment acquiring 380,172,862 shares of Langdi Technology, representing 19.08% of the total share capital of the company [1] - Prior to this transfer, Bubugao Investment did not hold any shares in the company [1] - Following the transfer, Shenzhen Shenshang Holdings Group will no longer hold any shares in the listed company [1] Group 2: Share Pledge and Freeze - As of the announcement date, Langdi Technology has pledged a total of 380,172,862 shares, which accounts for 100% of its held shares and 19.08% of the total share capital, with a pledge guarantee amounting to approximately 610 million yuan [1] - Additionally, a total of 252,324,862 shares have been frozen [1] Group 3: Future Plans - Bubugao Investment has stated that there are no specific plans to increase or decrease its shareholding in the listed company within the next 12 months, nor are there any major asset restructuring plans [1]

证券代码：600568 证券简称：ST 中珠 公告编号：2025-061 号 中珠医疗控股股份有限公司 关于第一大股东之股东股权发生变化暨权益变动的提示性公告 2025年11月24日，公司收到第一大股东朗地科技股东深商集团送达的《关于深圳 市朗地科技发展有限公司之股权转让协议》。深商集团于2025年11月23日与步步高投 资签署了《股权转让协议》，深商集团拟以3,000万元的价格将其持有的公司第一大股 东朗地科技100%股权转让给步步高投资。本次股权转让完成后，朗地科技控股股东由 深商集团变更为步步高投资。 截至本公告披露日，朗地科技持有上市公司380,172,862股股份，占公司总股本的 19.08%，为公司第一大股东。朗地科技累计质押股份数量为380,172,862股，占其持有 公司股份总数的100%，占公司总股本19.08%，质押担保金额约6.1亿元；累计冻结股份 数量为252,324,862股，占其所持公司股份总数66.37%，占公司总股本12.66%。具体内 容详见公司于2024年4月2日披露的《中珠医疗控股股份有限公司关于持股5%以上股东 部分股份解除质押及再质押的公告》（公告编号：2024-01 ...

Core Viewpoint - ST Zhongzhu announced the transfer of 100% equity of its largest shareholder, Shenzhen Landi Technology Development Co., Ltd. (Landi Technology), from Shenzhen Shenshang Holdings Group Co., Ltd. (Shenshang Group) to Suzhou Bubugao Investment Development Co., Ltd. (Bubugao Investment) for a price of 30 million yuan [1][2] Group 1 - The equity transfer agreement was signed on November 23, 2025, and the transfer price is set at 30 million yuan [1] - Landi Technology has pledged a total of 380,172,862 shares, representing 100% of its holdings and 19.08% of the total share capital of the company, with a pledge guarantee amount of approximately 610 million yuan [1] - Additionally, 252,324,862 shares have been frozen, accounting for 66.37% of Landi Technology's holdings and 12.66% of the company's total share capital [1] Group 2 - After the completion of the equity transfer, Bubugao Investment will become the controlling shareholder of Landi Technology, while Shenshang Group will no longer hold any shares in the listed company [2] - Bubugao Investment has no plans to increase or decrease its shareholding in the listed company within the next 12 months and does not intend to seek control of the company [2] - Prior to this equity change, Bubugao Investment did not hold any shares in the company, and after the change, it holds 380,172,862 shares, which is 19.08% of the total share capital [2]